Neo-Epitope Discovery & Therapy

References with Neo-Epitope Peptide Tools

New Epitopes in Ovalbuminprovide Insights For Cancer Neoepitopes
Karandikar et al, Immunology (2019)
Mass Spectrometry Driven Exploration Reveals Nuancesof Neoepitope-Driven Tumor Rejection
Ebrahimi-Nik et al, JCI Insight (2019)
Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine
Daeg et al, Biomacromolecules  (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Keskin et al, Nature (2019)
Identification and ranking of recurrent neo-epitopes in cancer
Blanc et al, BMC Med Gen (2019)
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms     
Bozkus et al, Cancer Discovery (2019)
CD11c+ MHCIIlo GM-CSF-bone marrow-derived dendritic cells act as antigen donor cells and as antigen presenting cells in neoepitope-elicited tumor immunity against a mouse fibrosarcoma
Ebrahimi-Nik et al, Cancer Immunol Immunother. (2018)
Personalized ex vivo Multiple Peptide Enrichment and Detection of T Cells Reactive to Multiple Tumor-associated Antigens in Prostate Cancer Patients  
Taborska  et al, Med Oncol.  (2017)
Personalized RNA Mutanome Vaccines Mobilize Poly-specific Therapeutic Immunity Against Cancer
Sahin et al, Nature (2017)
An Immunogenic Personal Neoantigen Vaccine for Patients with Melanoma
Ott et al, Nature (2017)
RNA Vaccination Therapy: Advances in an Emerging Field
Thielemans et al, Journal of Immunology Research (2016)
Increased IgG Antibody Responses to Neoepitope and Native Peptides Containing High Affinity Domains for MHCI Following Combination Cancer Immunotherapy
Hulett et al, Cancer Research (2016)

Further references



Check our list of products,
click and go.

Quality Assurance

All production is performed according to ISO 9001:2015 standards

Stay in touch and be the first to receive the latest news!